decanoylcarnitine

therapeutic agent for diabetic acidosis; RN given refers to cpd without isomeric designation

Also Known As:

decanoylcarnitine, (+-)-isomer; decanoylcarnitine, (R)-isomer; decanoylcarnitine, (S)-isomer

Networked: 17 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amines: 4871
  - Quaternary Ammonium Compounds: 136
    - Trimethyl Ammonium Compounds: 1
      - Carnitine: 4291
        decanoylcarnitine: 17

Experts

1.	Jung, Saem: 2 articles (01/2015 - 07/2014)
2.	Kim, Minjoo: 2 articles (01/2015 - 07/2014)
3.	Lee, Jong Ho: 2 articles (01/2015 - 07/2014)
4.	Lee, Sang-Hyun: 2 articles (01/2015 - 07/2014)
5.	Arai-Ichinoi, Natsuko: 1 article (12/2020)
6.	Kanno, Tomoe: 1 article (12/2020)
7.	Kure, Shigeo: 1 article (12/2020)
8.	Kurihara, Ai: 1 article (12/2020)
9.	Maekawa, Masamitsu: 1 article (12/2020)
10.	Mikami-Saito, Yasuko: 1 article (12/2020)

Related Diseases

1.	Medium chain acyl CoA dehydrogenase deficiency 12/01/2020 - "We experienced three neonatal cases with high levels of markers, octanoylcarnitine and octanoylcarnitine/decanoylcarnitine ratio used to pick up possible cases of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency. " 05/01/2008 - "The first 47 medium-chain acyl-CoA dehydrogenase deficiency cases detected by the New England Newborn Screening Program were classified according to initial and follow-up octanoylcarnitine values, octanoylcarnitine-decanoylcarnitine ratios, medium-chain acyl-CoA dehydrogenase genotype, follow-up biochemical parameters, and feeding by breast milk or formula. " 02/01/1996 - "Amniocytes from a pregnancy at risk for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency produced a characteristic acylcarnitine profile with increased levels of octanoylcarnitine and decanoylcarnitine, indicative of MCAD deficiency. "
2.	Neoplasms (Cancer) 06/01/2018 - "Hydroxybutyrylcarnitine, decanoylcarnitine, propanoylcarnitine, carnitine, dodecanoylcarnitine, and norepinephrine sulfate were found in much higher concentrations in both cancer tissues (compared with the paired normal tissue) and in urine of cancer patients (compared with control urine). " 10/19/2022 - "Out of the 50 studied metabolites, (i) six were inversely associated with the risk of most cancer types: glutamine, butyrylcarnitine, lysophosphatidylcholine a C18:2, and three clusters of phosphatidylcholines (PCs); (ii) three were positively associated with most cancer types: proline, decanoylcarnitine, and one cluster of PCs; and (iii) 10 were specifically associated with particular cancer types, including histidine that was inversely associated with colorectal cancer risk and one cluster of sphingomyelins that was inversely associated with risk of hepatocellular carcinoma and positively with endometrial cancer risk. "
3.	Primary Graft Dysfunction 01/01/2018 - "In the remaining transplanted cases, 9 cases developed primary graft dysfunction (PGD) 3. For the metabolic profile at EVLP-1h, a logistic regression model based on palmitoyl-sphingomyelin, 5-aminovalerate, and decanoylcarnitine yielded a receiver operating characteristic (ROC) curve with an area under the curve (AUC) of 0.987 in differentiating PGD 3 from Non-PGD 3 outcomes. "
4.	Multiple Acyl Coenzyme A Dehydrogenase Deficiency 05/01/1993 - "Plasma and blood spots from a patient with multiple acyl-coenzyme A dehydrogenase deficiency contained C4-acylcarnitine, hexanoylcarnitine, octanoylcarnitine, and decanoylcarnitine. "
5.	Overweight 01/01/2015 - "Furthermore, the overweight group showed greater increases in L-octanoylcarnitine (q=0.006) and decanoylcarnitine (q=0.007), and higher peak intensities of L-leucine, L-octanoylcarnitine, and decanoylcarnitine. "

Related Drugs and Biologics

1.	octanoylcarnitine
2.	Acyl-CoA Dehydrogenase (Medium-Chain Acyl-Coenzyme A Dehydrogenase)
3.	Leucine (L-Leucine)
4.	butyrylcarnitine
5.	hexanoylcarnitine
6.	Biomarkers (Surrogate Marker)
7.	Sphingomyelins
8.	Phenylalanine (L-Phenylalanine)
9.	Carnitine (L-Carnitine)
10.	lauroylcarnitine